Urokinase Plasminogen Activator Receptor and Soluble Matrix Metalloproteinase-9 in Acute Myeloid Leukemia Patients: A Possible Relation to Disease Invasion

References

• Lin, L.I., Lin, D.T., Chang, C.J., Lee, C.Y., Tang, J.L. and Tien, H.F. (2002) "Marrow matrix metalloproteinase (MMPs) and tissue inhibitors of MMP in acute leukemia: Potential role of MMP-9 as a surrogate marker to monitor leukemic status in patients with acute myelogenous leukemia", Br. J. Hematol. 117(4), 835–841.
   PubMed Web of Science ®Google Scholar
• Ries, C., Loher, E, Zang, C., Ismair, M.G. and Petrides, P.E. (1999) "Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes", Clin. Cancer Res. 5(5), 1115–1124.
   PubMed Web of Science ®Google Scholar
• Pauli, B.U., Schwartz, D.E., Thonar, E.J. and Kuettner, K.E. (1983) "Tumor invasion and host extracellular matrix", Cancer Metastasis Rev. 2(2), 129–152.
   PubMed Web of Science ®Google Scholar
• Moscatelli, D. and Rifkin, D.B. (1988) "Membrane and matrix localization of proteinases; a common theme in tumor cell invasion and angiogenesis", Biochem. Biophys. Acta 948(1), 67–85.
   PubMed Web of Science ®Google Scholar
• Lanaza, F., Castoldi, CL., Castagnari, B., Todd, R.F., Moretti, S., Spisani, S., Latorraca, A., Focarile, E., Roberti, M.G. and Traniello, S. (1998) "Expression and functional role of urokinase-type plasminogen activator receptor in normal and acute leukemic cells", Br. J. Hematol. 103(1), 110–123.
   PubMed Web of Science ®Google Scholar
• Bajou, K. (2002) "Role of PAI-1 plasminogen activator inhibitor in tumor invasion and angiogenesis", Bull. Mem. Acad. R. Med. Belg. 157(5-6), 313–318.
   PubMedGoogle Scholar
• Zhao, W., Wang, X., Qu, B., Huang, X. and Wang, H. (2002) "Clinical significance of plasma tissue factor pathway and urokinase-type plasminogen activator system in cancer patients", Chin. Med. J. (Engl.) 115(5), 702–704.
   PubMed Web of Science ®Google Scholar
• Liotta, L.A. and Stetler-Stevenson, W.G. (1991) "Tumor invasion and metastasis: an imbalance of positive and negative regulation", J. Cancer Res. 51\(Suppl. 18), 5054s–5059s.
   Google Scholar
• Zucker, S., Lysik, R.M., di-Massimo, B.I., Zarrabi, H.M., Moll, U.M., Crimson, R., Tickle, S.P. and Docherty, A.J. (1995) "Plasma assay of glatinase B: tissue inhibitor of metallo-proteinase complexes in cancer", Cancer 76(4), 700–708.
   PubMed Web of Science ®Google Scholar
• Ries, C. and Petrides, P.E. (1995) "Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunc-tion in disease", Biol. Chem. Hoppe-Seyler 376(6), 345–355.
   PubMed Web of Science ®Google Scholar
• Tieghi, A., Ciccone, M., Bragotti, Z.L., Cavazzini, E, Porta, M.D., Castagnari, B., Carroccia, R., Guerra, G., Cuneo, A. and Castoldi, G. (2003) "Soluble urokinase-type plasminogen activator receptor (suPAR) as an independent factor predict-ing worse prognosis and extra-bone marrow involvement in multiple myeloma", Br. J. Hematol. 120(6), 953–959.
   PubMed Web of Science ®Google Scholar
• Mori, N., Sato, H., Hayashibara, T., Senba, M., Hayashi, T., Yamada, Y, Kamihira, S., Ikeda, S., Yamasaki, Y, Morikawa, S., Tomonaga, M., Geleziunas, G. and Yamamoto, N. (2001) "Human T-cell leukemia virus Type I Tax transactivates the matrix metalloproteinase 9 gene:potential role in mediating adult T-cell leukemia invasiveness", Blood 99(4), 1341–1349.
   Web of Science ®Google Scholar
• Jensen, M.K., Riisbro, R., de Nullly Brown, P., Brunner, N. and Hasselbach, H.C. (2002) "Elevated soluble urokinase plasmi-nogen activator receptor in plasma from patients with idiopathic myelofibrosis or polycythemia vera", Fur. J. Hematol. 69(1), 43–49.
   Google Scholar
• Hayashibara, T., Ymada, Y, Onimaru, Y., Tsutsumi, C., Nakayama, S., Mori, N., Miyanishi, T., Kamihira, S., Tomonaga, M. and Maita, T. (2002) "Matrix metalloprotei-nase-9 and vascular endothelial growth factor. A possible link in adult T-cell leukemia cell invasion", Br. J. Hematol. 116(1), 94–102.
   PubMed Web of Science ®Google Scholar
• Guan, K.P., Ye, H.Y., Yan, Z., Wang, Y. and Hou, S.K. (2003) "Serum levels of endostatin and matrix metalloproteinase-9 associated with high stage and grade primary transitional cell carcinoma of bladder", Urology 61(4), 719–723.
   PubMed Web of Science ®Google Scholar
• Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A., Gralnick, H.R. and Sultan, C. (1985) "Proposed revised criteria for classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group", Ann. Intern. Med. 103(4), 620–625.
   PubMed Web of Science ®Google Scholar
• Cheson, B.D., Cassilteth, P.A., Head, DR., Schiffer, C.A., Bennet, J.M. and Bloomfield, CD. (1990) "Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia", J. Clin. Oncol. 8(5), 813–819.
   PubMed Web of Science ®Google Scholar
• Bene, M.C., Castoldi, G., Knapp, W., Ludwing, W.D., Matutes, E. and Orfao, A. (1995) "European Group for immunological classification of acute leukemias", Leukemia 9(10), 1783–1786.
   PubMed Web of Science ®Google Scholar
• Munoz, L., Aveentin, A., Villamor, N., Junca, J., Acebedo, G., Domingo, A., Rozman, M., Torres, J.P., Tormo, M. and Nomdedeu, J.F. (2003) "Immunophenotypic findings in acute leukemia with F1t3 internal Tandem duplication", Hemato-logica 88(6), 637–645.
   PubMed Web of Science ®Google Scholar
• Stephens, R.W., Pedersen, A., Nielsen, H.J., Hamers, M., Hoyer-Hansen, G., Ronne, E., Dybkjaer, E., Dane, K. and Brurmer, N. (1997) "ELISA determination of soluble uro-kinase receptor in blood from healthy donors and cancer patients", Clin. Chem. 43(10), 1868–1876.
   PubMed Web of Science ®Google Scholar
• Ronne, E., Pappot, H., Grondahl-Hansen, J., Hoyer-Hansen, G., Plesner, T., Hansen, N.E. and Dano, K. (1995) "The receptor for urokinase plasminogen activator is present in plasma from healthy donors and elevated in patients with paroxysmal nocturnal hemoglobinuria", Br. J. Hematol. 89(3), 576–581.
   PubMed Web of Science ®Google Scholar
• Wahlberg, K., Hoyer-Hansen, G. and Casslen, B. (1998) "Soluble receptor for urokinase plasminogen length and a cleaved form is present in high concentration in cystic fluid from ovarian cancer", Cancer Res. 58(15), 3294–3298.
   PubMed Web of Science ®Google Scholar
• Sier, CF., Sidenius, N., Mariani, A., Aletti, G., Agape, V, Ferrari, A., Casetta, G., Stephens, R.W., Brunner, N. and Blasi, F. (1999) "Presence of urokinase-type plasminogen activator receptor in urine of cancer patients and its possible clinical relevance", Lab. Investig. 79(6), 717–722.
   PubMed Web of Science ®Google Scholar
• Janowska-Wieczorek, A., Marquez, L.A., Matsuzaki, A., Hashmi, H.R., Larratt, L.M., Boshkov, L.M., Turner, A.R., Zhang, M.C., Edwards, D.R. and Kossakowska, A.E. (1999) "Expression of matrix metalloproteinases (MMP-2 and MMP-9) and tissue inhibitors of metalloproteinases (TIMP-1 and -2) in acute myelogenous leukemia blasts: comparison with normal bone marrow cells", Br. J. Hemato 1105(2), 402–411.
   Google Scholar
• Goetzl, E.J., Banda, M.J. and Leeppert, D. (1996) "Matrix metalloproteinases in immunity", J. Immunol. 156(1), 1–4.
   PubMed Web of Science ®Google Scholar
• Delclaux, C., Delacourt, C., D'Ortho, M., Boyer, V, Lafuma, C. and Harf, A. (1996) "Role of gelatinase B and elastase in human polymorph nuclear neutrophil migration across basement membrane", Am. J. Respir. Cell Mol. Biol. 14(3), 288–295.
   PubMed Web of Science ®Google Scholar
• Matsuzaki, A. and Janowska-Wieczorek, A. (1997) "Unsti-mulated human acute myelogenous leukemia blasts secrete matrix metalloproteinases", J. Cancer Res. Clin. Oncol. 123(2), 100–106.
   PubMed Web of Science ®Google Scholar
• Mustjoki, S., Sidenius, N., Sier, C.F.M., Blasi, E, Elonen, E., Alitalo, R. and Vaheri, A. (2000) "Soluble urokinase receptor levels correlate with number of circulating tumor cells in acute myeloid leukemia and decrease rapidly during chemotherapy", Cancer Res. 60(15), 7126–7132.
   PubMedGoogle Scholar